Prostate and Bladder Cancer Detection and Classification Technology

Molecular Diagnostic Prostate Cancer Testing

Unlike other available blood and urine tests, the miR platform produces a molecular characterization of the likelihood of malignant progression, allowing for far more accurate results.

We capture and lyse exosomes from the patient’s urine sample, then interrogate the extracted sncRNA in a high-throughput OpenArray™ system. Our proprietary algorithm calculates patient results and provides clear Yes/No cancer detection and High Risk/Intermediate Risk/Low Risk classification.

Accurate Classification Guides Clinical Pathways

miR’s unique sncRNA extraction and interrogation techniques coupled with an advanced proprietary algorithm will allow physicians to confidently detect and classify prostate cancers with just one urine sample, eliminating unnecessary treatments for prostate cancer patients.

Our validation studies have shown the extraordinary accuracy of miR`s molecular prostate cancer detection and classification technology.